Page 81 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. Advancing Progress in the Development and Implementation of Effective, High-Quality Cancer Screening: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26019.

×

Appendix B

Workshop Agenda

MARCH 2, 2020

7:30 a.m.	Registration
8:00 a.m.	Welcome from the National Cancer Policy Forum Nicole Dowling, Centers for Disease Control and Prevention Planning Committee Co-Chair
8:00 a.m.	Stanton Gerson, Case Comprehensive Cancer Center Planning Committee Co-Chair
8:10 a.m.	Session 1: Principles and Methods of Cancer Screening Moderator: Sue Curry, The University of Iowa
	Overview of Cancer Screening Otis Brawley, Johns Hopkins University Barnett Kramer, National Cancer Institute
	Frameworks for Assessing the Evidence Base for Cancer Screening Recommendations Alex Krist, Virginia Commonwealth University
	Panel Discussion
9:30 a.m.	Break

Page 82 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. Advancing Progress in the Development and Implementation of Effective, High-Quality Cancer Screening: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26019.

×

9:45 a.m.	Session 2: The Evidence Base for Cancer Screening: Key Gaps and Statistical and Methodological Challenges Moderator: Constantine Gatsonis, Brown University
	Statistical and Methodological Challenges in Cancer Screening Ruth Etzioni, Fred Hutchinson Cancer Research Center
	Quantitative Approaches to Summarizing the Benefits and Risks of Screening Carolyn Rutter, RAND Corporation
	Assessing the Evidence Base for Cancer Screening as New Technologies Are Developed David Ransohoff, University of North Carolina at Chapel Hill
	Health Economics of Cancer Screening Jeanne Mandelblatt, Georgetown University
	Panel Discussion
11:45 a.m.	Lunch Break
12:45 p.m.	Session 3: Opportunities and Challenges in the Validation and Implementation of Novel Screening Technologies Moderator: Sudhir Srivastava, National Cancer Institute
	Challenges with Validation of Novel Screening Tests Arul Chinnaiyan, University of Michigan
	Novel Screening Technologies and Approaches
	Risk-Based Prostate Cancer Screening Peter Albers, Heinrich-Heine-University, Düsseldorf
	Ovarian Cancer Screening Usha Menon, University College London
	Noninvasive Multicancer Screening Using Liquid Biopsy Nickolas Papadopoulos, Johns Hopkins University

Page 83 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. Advancing Progress in the Development and Implementation of Effective, High-Quality Cancer Screening: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26019.

×

	Panel Discussion Speakers, plus: Hedvig Hricak, Memorial Sloan Kettering Cancer Center Wendy Rubinstein, Food and Drug Administration Sara Brenner, Food and Drug Administration
3:00 p.m.	Break
3:15 p.m.	Session 4: Patient Access to High-Quality Cancer Screening and Follow-Up Care Moderator: Stanton Gerson, Case Comprehensive Cancer Center
	The Screening Process: Ensuring Patient Access Among Vulnerable Populations Jacqueline Miller, Centers for Disease Control and Prevention National Breast and Cervical Cancer Early Detection Program
	Patient, Clinician, and Organizational Barriers to Timely Diagnosis Ann Geiger, National Cancer Institute Division of Cancer Control and Population Sciences
	Cervical Cancer Screening and Follow-Up Care Within the Challenging Context of U.S.–Mexico Border Communities Kathleen Schmeler, MD Anderson Cancer Center
	Ethical Considerations in the Assessment of Cancer Screening Benefits and Risks Rebecca Pentz, Emory University
	Panel Discussion
5:15 p.m.	Adjourn Day 1

Page 84 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. Advancing Progress in the Development and Implementation of Effective, High-Quality Cancer Screening: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26019.

×

MARCH 3, 2020

7:30 a.m.	Registration
8:00 a.m.	Session 5: Shared Decision Making and Communication in Screening Moderator: Alex Krist, Virginia Commonwealth University
	Strategies to Promote Shared Decision Making Michael J. Barry, Massachusetts General Hospital
	Decision Aids and Shared Decision-Making Implementation Michael Pignone, The University of Texas at Austin
	Improving Cancer Screening Communication and Shared Decision Making Among Diverse Populations Masahito Jimbo, University of Michigan
	Personalizing Cancer Screening Decision Making and Follow-Up Care Laura Esserman, University of California, San Francisco
	Panel Discussion
9:45 a.m.	Break
10:15 a.m.	Session 6: Participant Recommendations to Improve Cancer Screening Moderator: Otis Brawley, Johns Hopkins University
	Gwen Darien, National Patient Advocate Foundation Alex Krist, Virginia Commonwealth University and United States Preventive Services Task Force J. Leonard Lichtenfeld, American Cancer Society Jacqueline Miller, Centers for Disease Control and Prevention Rebecca Pentz, Emory University Sudhir Srivastava, National Cancer Institute
11:30 a.m.	Workshop Wrap-Up Nicole Dowling, Centers for Disease Control and Prevention Planning Committee Co-Chair
11:45 a.m.	Adjourn